Skip to main content

Table 2 QALY weights applied

From: Revisiting the cost-effectiveness of universal HPV-vaccination in Denmark accounting for all potentially vaccine preventable HPV-related diseases in males and females

QALY weights the general population 1    
  Men Women   QALY
Age group QALY QALY Occurrence/illness Utility score2 Duration
15-19 0.9373 0.9203    
20-24 0.9373 0.9203 CIN1 0.93 2 months
25-29 0.9373 0.9203    
30-34 0.9355 0.9118 CIN2-3 0.87 2 months
35-39 0.9197 0.8898    
40-44 0.9118 0.8763 Genital warts 0.91 85 days
45-49 0.9050 0.8751    
50-54 0.8813 0.8499 Cervical cancer, fatal 0.76-0, 67  
55-59 0.8870 0.8542 Cervical cancer, survivors 0.76 5 years
60-64 0.8747 0.8552    
65-69 0.8801 0.8098 Genital cancer, fatal 0.76-0.67  
70-74 0.8437 0.8320 Genital cancer, survivors 0.76 5 years
75-79 0.8429 0.7837    
80-84 0.7855 0.6919 Head & neck cancer, fatal 0.76-0.67  
85- 0.7855 0.6919 Head & neck cancer, survivors 0.76 5 years
  1. 1Unpublished data from survey performed by National Institute of Public Health, University of Southern Denmark (personal communication). These data, pooled with two other Danish surveys, are published on a more aggregate level in Sørensen et al., 2009 [31].
  2. 2Source: [18].